Research programme: RAS inducers- Immuneering
Alternative Names: RAS induction - ImmuneeringLatest Information Update: 20 Apr 2022
At a glance
- Originator Immuneering
- Class Antineoplastics; Small molecules
- Mechanism of Action Ras protein stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Solid tumours